Belimumab

Nat Rev Drug Discov. 2011 May;10(5):335-6. doi: 10.1038/nrd3436.
No abstract available

Publication types

  • News

MeSH terms

  • Animals
  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal / pharmacology
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • B-Cell Activating Factor / immunology*
  • Drug Approval
  • Humans
  • Lupus Erythematosus, Systemic / drug therapy*
  • Lupus Erythematosus, Systemic / immunology
  • United States
  • United States Food and Drug Administration

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • B-Cell Activating Factor
  • belimumab